The Latin America, Middle East and Africa Neurovascular Catheters Market should witness market growth of 10.6% CAGR during the forecast period (2023-2029).
The adaptability of neurovascular catheters is one of the features that play a role in determining their level of use. These catheters have been developed with the capability of being molded into a range of different shapes so that they can meet the needs of the person who will ultimately utilize them. Reputable businesses are currently working on the research and development of highly developed and individualized product solutions for neurovascular catheters in order to carry out minimally invasive surgery.
For instance, balloon catheters can be created in an array of lengths and sizes to carry out minimally invasive diagnostic and therapeutic treatments, such as enlarging arteries, removing obstructions, and delivering stents. These procedures include extending the lumen of blood vessels, removing obstructions, and delivering stents.
The neurovascular catheter market is experiencing swift technological progress, leading to the development of innovative products that offer improved features and benefits. As a result, the growing need for neurovascular catheters is expected to rise in the upcoming years.
Israel's aging population is in line with demographic trends. The 65+ age demographic has grown 18 times since 1950. Based on forecasts, the elderly demographic in Israel is anticipated to comprise 14% of the overall population, equivalent to 1.9 million individuals, by the year 2035. In the year of Israel's establishment, 1948, older people comprised a mere 4% of the population. In addition, there has been a steady 1% annual increase in life expectancy since 1995, which is expected to continue. The rising aging population in the area is anticipated to increase the need for neurovascular catheters, given that this group is more prone to neurological diseases like brain aneurysms, which utilize catheters for treatment, thereby surging the market growth in LAMEA.
The Brazil market dominated the LAMEA Neurovascular Catheters Market by Country in 2022; thereby, achieving a market value of $80.2 million by 2029. The Argentina market is experiencing a CAGR of 11.2% during (2023-2029). Additionally, The UAE market would exhibit a CAGR of 10.3% during (2023-2029).
Based on Type, the market is segmented into Embolization Catheters, Access Catheters, Balloon Catheters, Microcatheters and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on Application, the market is segmented into Brain Aneurysm, Embolic Stroke, Arteriovenous Malformations and Hydrolysate. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG).
The adaptability of neurovascular catheters is one of the features that play a role in determining their level of use. These catheters have been developed with the capability of being molded into a range of different shapes so that they can meet the needs of the person who will ultimately utilize them. Reputable businesses are currently working on the research and development of highly developed and individualized product solutions for neurovascular catheters in order to carry out minimally invasive surgery.
For instance, balloon catheters can be created in an array of lengths and sizes to carry out minimally invasive diagnostic and therapeutic treatments, such as enlarging arteries, removing obstructions, and delivering stents. These procedures include extending the lumen of blood vessels, removing obstructions, and delivering stents.
The neurovascular catheter market is experiencing swift technological progress, leading to the development of innovative products that offer improved features and benefits. As a result, the growing need for neurovascular catheters is expected to rise in the upcoming years.
Israel's aging population is in line with demographic trends. The 65+ age demographic has grown 18 times since 1950. Based on forecasts, the elderly demographic in Israel is anticipated to comprise 14% of the overall population, equivalent to 1.9 million individuals, by the year 2035. In the year of Israel's establishment, 1948, older people comprised a mere 4% of the population. In addition, there has been a steady 1% annual increase in life expectancy since 1995, which is expected to continue. The rising aging population in the area is anticipated to increase the need for neurovascular catheters, given that this group is more prone to neurological diseases like brain aneurysms, which utilize catheters for treatment, thereby surging the market growth in LAMEA.
The Brazil market dominated the LAMEA Neurovascular Catheters Market by Country in 2022; thereby, achieving a market value of $80.2 million by 2029. The Argentina market is experiencing a CAGR of 11.2% during (2023-2029). Additionally, The UAE market would exhibit a CAGR of 10.3% during (2023-2029).
Based on Type, the market is segmented into Embolization Catheters, Access Catheters, Balloon Catheters, Microcatheters and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on Application, the market is segmented into Brain Aneurysm, Embolic Stroke, Arteriovenous Malformations and Hydrolysate. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG).
Scope of the Study
By Type
- Embolization Catheters
- Access Catheters
- Balloon Catheters
- Microcatheters
- Others
By End-use
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
By Application
- Brain Aneurysm
- Embolic Stroke
- Arteriovenous Malformations
- Hydrolysate
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Stryker Corporation
- Terumo Corporation
- Integer Holdings Corporation
- Penumbra, Inc.
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Integra LifeSciences Corporation
- Acandis GmbH
- Spiegelberg GmbH & Co. KG
- RAUMEDIC AG (REHAU Industries SE & Co. KG)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Neurovascular Catheters Market, by Type
1.4.2 LAMEA Neurovascular Catheters Market, by End Use
1.4.3 LAMEA Neurovascular Catheters Market, by Application
1.4.4 LAMEA Neurovascular Catheters Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Analyst's Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Trials and Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. LAMEA Neurovascular Catheters Market by Type
4.1 LAMEA Embolization Catheters Market by Country
4.2 LAMEA Access Catheters Market by Country
4.3 LAMEA Balloon Catheters Market by Country
4.4 LAMEA Microcatheters Market by Country
4.5 LAMEA Others Market by Country
Chapter 5. LAMEA Neurovascular Catheters Market by End-use
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Clinics Market by Country
5.3 LAMEA Ambulatory Surgical Centers Market by Country
5.4 LAMEA Diagnostic Centers Market by Country
Chapter 6. LAMEA Neurovascular Catheters Market by Application
6.1 LAMEA Brain Aneurysm Market by Country
6.2 LAMEA Embolic Stroke Market by Country
6.3 LAMEA Arteriovenous Malformations Market by Country
6.4 LAMEA Hydrolysate Market by Country
Chapter 7. LAMEA Neurovascular Catheters Market by Country
7.1 Brazil Neurovascular Catheters Market
7.1.1 Brazil Neurovascular Catheters Market by Type
7.1.2 Brazil Neurovascular Catheters Market by End-use
7.1.3 Brazil Neurovascular Catheters Market by Application
7.2 Argentina Neurovascular Catheters Market
7.2.1 Argentina Neurovascular Catheters Market by Type
7.2.2 Argentina Neurovascular Catheters Market by End-use
7.2.3 Argentina Neurovascular Catheters Market by Application
7.3 UAE Neurovascular Catheters Market
7.3.1 UAE Neurovascular Catheters Market by Type
7.3.2 UAE Neurovascular Catheters Market by End-use
7.3.3 UAE Neurovascular Catheters Market by Application
7.4 Saudi Arabia Neurovascular Catheters Market
7.4.1 Saudi Arabia Neurovascular Catheters Market by Type
7.4.2 Saudi Arabia Neurovascular Catheters Market by End-use
7.4.3 Saudi Arabia Neurovascular Catheters Market by Application
7.5 South Africa Neurovascular Catheters Market
7.5.1 South Africa Neurovascular Catheters Market by Type
7.5.2 South Africa Neurovascular Catheters Market by End-use
7.5.3 South Africa Neurovascular Catheters Market by Application
7.6 Nigeria Neurovascular Catheters Market
7.6.1 Nigeria Neurovascular Catheters Market by Type
7.6.2 Nigeria Neurovascular Catheters Market by End-use
7.6.3 Nigeria Neurovascular Catheters Market by Application
7.7 Rest of LAMEA Neurovascular Catheters Market
7.7.1 Rest of LAMEA Neurovascular Catheters Market by Type
7.7.2 Rest of LAMEA Neurovascular Catheters Market by End-use
7.7.3 Rest of LAMEA Neurovascular Catheters Market by Application
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.1.6 SWOT Analysis
8.2 Johnson & Johnson (Johnson & Johnson Services, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Penumbra, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Approvals and Trials:
8.4 Integer Holdings Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Geographical Expansions:
8.5 Terumo Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Regional Analysis
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Stryker Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Approvals and Trials:
8.6.5.2 Geographical Expansions:
8.7 Integra LifeSciences Holdings Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Acandis GmbH
8.8.1 Company Overview
8.9 Spiegelberg GmbH & Co. KG.
8.9.1 Company Overview
8.10. RAUMEDIC AG (REHAU Industries SE & Co. KG)
8.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Stryker Corporation
- Terumo Corporation
- Integer Holdings Corporation
- Penumbra, Inc.
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Integra LifeSciences Corporation
- Acandis GmbH
- Spiegelberg GmbH & Co. KG
- RAUMEDIC AG (REHAU Industries SE & Co. KG)
Methodology
LOADING...
